Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type.

IF 2.5 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiovascular Pharmacology and Therapeutics Pub Date : 2021-09-01 Epub Date: 2021-04-09 DOI:10.1177/10742484211005929
Truong H Hoang, Pavel V Lazarev, Victor V Maiskov, Imad A Merai, Zhanna D Kobalava
{"title":"Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type.","authors":"Truong H Hoang,&nbsp;Pavel V Lazarev,&nbsp;Victor V Maiskov,&nbsp;Imad A Merai,&nbsp;Zhanna D Kobalava","doi":"10.1177/10742484211005929","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atherothrombosis is the principal mechanism of type 1 (T1) myocardial infarction (MI), while type 2 (T2) MI is typically diagnosed in the presence of triggers (anemia, arrhythmia, etc.). We aimed to evaluate the proportions of T1 vs. T2 MI based on angiographic and clinical definitions, their concordance and prognosis.</p><p><strong>Methods: </strong>Consecutive MI patients [n = 712, 61% male; age 64.6 ± 12.3 years] undergoing coronary angiography were classified according to the presence of atherothrombosis and identifiable triggers. Association of angiographic and clinical MI type criteria with adverse outcomes (Time follow-up was 1.5 years) was evaluated. Predictive ability of GRACE risk score for all-cause mortality was then assessed.</p><p><strong>Results: </strong>Atherothrombosis and clinical triggers were identified in 397 (55.6%) and 324 (45.5%) subjects, respectively. Only 247 (34.7%) patients had \"true\" T1MI (atherothrombosis+ / triggers-); 174 (24.4%) were diagnosed with \"true\" T2MI (atherothrombosis- / triggers+), while 291 (40.9%) had discordant clinical and angiographic characteristics. All-cause mortality in T2MI (20.1%) patients was higher than in T1MI (9.3%), <i>P</i> = 0.002. Presence of triggers [odds ratio (OR) 2.4, 95% CI 1.5-3.6, <i>P</i> < 0.0001] but not atherothrombosis [OR 0.8, 95% confidence interval (CI) 0.5-1.3, <i>P</i> = 0.26] was associated with worse prognosis. GRACE score is a better predictor of death in T1MI vs. T2MI: area under curve 0.893 (95% CI 0.830-0.956) vs 0.748 (95% CI 0.652-0.843), <i>P</i> = 0.013.</p><p><strong>Conclusion: </strong>Angiographic and clinical definitions of MI type are discordant in a substantial proportion of patients. Clinical triggers are associated with all-cause mortality. Predictive performance of GRACE score is worse in T2MI patients.</p>","PeriodicalId":15281,"journal":{"name":"Journal of Cardiovascular Pharmacology and Therapeutics","volume":"26 5","pages":"463-472"},"PeriodicalIF":2.5000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10742484211005929","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Pharmacology and Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10742484211005929","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Atherothrombosis is the principal mechanism of type 1 (T1) myocardial infarction (MI), while type 2 (T2) MI is typically diagnosed in the presence of triggers (anemia, arrhythmia, etc.). We aimed to evaluate the proportions of T1 vs. T2 MI based on angiographic and clinical definitions, their concordance and prognosis.

Methods: Consecutive MI patients [n = 712, 61% male; age 64.6 ± 12.3 years] undergoing coronary angiography were classified according to the presence of atherothrombosis and identifiable triggers. Association of angiographic and clinical MI type criteria with adverse outcomes (Time follow-up was 1.5 years) was evaluated. Predictive ability of GRACE risk score for all-cause mortality was then assessed.

Results: Atherothrombosis and clinical triggers were identified in 397 (55.6%) and 324 (45.5%) subjects, respectively. Only 247 (34.7%) patients had "true" T1MI (atherothrombosis+ / triggers-); 174 (24.4%) were diagnosed with "true" T2MI (atherothrombosis- / triggers+), while 291 (40.9%) had discordant clinical and angiographic characteristics. All-cause mortality in T2MI (20.1%) patients was higher than in T1MI (9.3%), P = 0.002. Presence of triggers [odds ratio (OR) 2.4, 95% CI 1.5-3.6, P < 0.0001] but not atherothrombosis [OR 0.8, 95% confidence interval (CI) 0.5-1.3, P = 0.26] was associated with worse prognosis. GRACE score is a better predictor of death in T1MI vs. T2MI: area under curve 0.893 (95% CI 0.830-0.956) vs 0.748 (95% CI 0.652-0.843), P = 0.013.

Conclusion: Angiographic and clinical definitions of MI type are discordant in a substantial proportion of patients. Clinical triggers are associated with all-cause mortality. Predictive performance of GRACE score is worse in T2MI patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心肌梗死类型的血管造影和临床定义的一致性和预后相关性。
背景:动脉粥样硬化血栓形成是1型(T1)心肌梗死(MI)的主要机制,而2型(T2)心肌梗死通常在存在触发因素(贫血、心律失常等)时诊断。我们的目的是根据血管造影和临床定义、它们的一致性和预后来评估T1和T2心肌梗死的比例。方法:连续的心肌梗死患者[n = 712, 61%为男性;年龄(64.6±12.3岁)根据有无动脉粥样硬化形成及可识别的触发因素进行冠状动脉造影。评估血管造影和临床心肌梗死类型标准与不良结局的关系(随访时间为1.5年)。然后评估GRACE风险评分对全因死亡率的预测能力。结果:在397例(55.6%)和324例(45.5%)受试者中分别发现动脉粥样硬化血栓形成和临床触发因素。只有247例(34.7%)患者为“真”T1MI(动脉粥样硬化+ /诱因-);174例(24.4%)被诊断为“真正的”T2MI(动脉粥样硬化血栓形成- /触发+),291例(40.9%)的临床和血管造影特征不一致。T2MI患者的全因死亡率(20.1%)高于T1MI患者(9.3%),P = 0.002。诱发因素的存在[比值比(OR) 2.4, 95% CI 1.5-3.6, P < 0.0001]但与动脉粥样硬化血栓形成无关[比值比(OR) 0.8, 95%可信区间(CI) 0.5-1.3, P = 0.26]与预后不良相关。GRACE评分能更好地预测T1MI与T2MI的死亡:曲线下面积0.893 (95% CI 0.830-0.956) vs 0.748 (95% CI 0.652-0.843), P = 0.013。结论:相当比例的患者心肌梗死类型的血管造影和临床定义不一致。临床诱因与全因死亡率有关。T2MI患者GRACE评分的预测性能较差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.00
自引率
0.00%
发文量
33
审稿时长
6-12 weeks
期刊介绍: Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) is a peer-reviewed journal that publishes original basic human studies, animal studies, and bench research with potential clinical application to cardiovascular pharmacology and therapeutics. Experimental studies focus on translational research. This journal is a member of the Committee on Publication Ethics (COPE).
期刊最新文献
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis Exposure to Electronic Waterpipes Increases the Risk of Occlusive Cardiovascular Disease in C57BL/6J Mice Thanks to Reviewers Prognostic Implications of Immature Platelet Fraction at 5-Year Follow-up Among ACS Patients Treated With Dual Antiplatelet Therapy. Assessment of Dofetilide or Sotalol Tolerability in the Elderly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1